717-703-0804
On Monday, a renewed request was filed to remove the DEA as the proponent of the rulemaking that proposes to reschedule cannabis as a Schedule III substance under the Controlled Substances Act. A similar request was made in November and was rejected by the parties now asking the assigned judge to reconsider his earlier decision. This time around the cannabis proponents assert there is “newly discovered evidence” that has come to light that ultimately warrants the removal of DEA from the proceedings. Some of the allegations the proponents lodge at the DEA include conflicts of interest, ex parte communications, and improper and late-filed submissions that show the DEA is hostile to the rescheduling for which they are tasked with advocating.
The DEA has until January 13 to file a response. The hearings are scheduled to commence on January 21.
